Klinikum der Universität München (LMU Klinikum)

7. Ringversuch Arzneimittelinformation der ADKA (2024) Strobach D, Hehr J, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program (2024) Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, et al. Journal article The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects (2024) Ertl C, Ruf T, Mentzer D, Kong M, Kramer R, Bergwelt-Baildon Mv, Subklewe M, et al. Journal article Prospective associations of technostress at work, burnout symptoms, hair cortisol, and chronic low-grade inflammation (2024) Kaltenegger HC, Marques MD, Becker L, Rohleder N, Nowak D, Wright BJ, Weigl M Journal article, Original article SOP – Aufnahmekriterien auf die Palliativstation (2024) Gärtner J, Jaroslawski K, Thuss-Patience P, Rosenbruch J, Böhlke C, Becker G Journal article Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12) (2024) Bodensohn R, Fleischmann DF, Maier SH, Anagnostatou V, Garny S, Nitschmann A, Büttner M, et al. Journal article The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours (2024) Hering S, Nieto A, Marschner S, Hofmaier J, Schmidt-Hegemann NS, da Silva Mendes V, Landry G, et al. Journal article Stereotactic body radiotherapy for pancreatic cancer – A systematic review of prospective data (2024) Shouman MA, Fuchs F, Walter F, Corradini S, Westphalen CB, Vornhülz M, Beyer G, et al. Journal article Simultaneous object detection and segmentation for patient-specific markerless lung tumor tracking in simulated radiographs with deep learning (2024) Huang L, Kurz C, Freislederer P, Manapov F, Corradini S, Niyazi M, Belka C, et al. Journal article Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade (2024) Schewe DM, Vogiatzi F, Münnich IA, Zeller T, Windisch R, Wichmann C, Müller K, et al. Journal article